Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation
dc.contributor.author | DeBosch, Brian J. | en_US |
dc.contributor.author | Baur, Elisabeth | en_US |
dc.contributor.author | Deo, Baljit K. | en_US |
dc.contributor.author | Hiraoka, Miki | en_US |
dc.contributor.author | Kumagai, Arno K. | en_US |
dc.date.accessioned | 2010-04-01T15:20:21Z | |
dc.date.available | 2010-04-01T15:20:21Z | |
dc.date.issued | 2001-05-15 | en_US |
dc.identifier.citation | DeBosch, Brian J.; Baur, Elisabeth; Deo, Baljit K.; Hiraoka, Miki; Kumagai, Arno K. (2001). "Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation." Journal of Neurochemistry 77(4): 1157-1167. <http://hdl.handle.net/2027.42/65813> | en_US |
dc.identifier.issn | 0022-3042 | en_US |
dc.identifier.issn | 1471-4159 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/65813 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11359881&dopt=citation | en_US |
dc.format.extent | 781809 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Ltd | en_US |
dc.rights | International Society for Neurochemistry | en_US |
dc.subject.other | Diabetic Retinopathy | en_US |
dc.subject.other | Glucose Transport | en_US |
dc.subject.other | GLUT1 | en_US |
dc.subject.other | Inner Blood–Retinal Barrier | en_US |
dc.subject.other | Insulin-like Growth Factor | en_US |
dc.subject.other | Retinal Endothelial Cells | en_US |
dc.title | Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Department of Internal Medicine, Michigan Diabetes Research and Training Center, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | † JDRF Center for Complications in Diabetes, University of Michigan Medical School, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 11359881 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/65813/1/j.1471-4159.2001.00325.x.pdf | |
dc.identifier.doi | 10.1046/j.1471-4159.2001.00325.x | en_US |
dc.identifier.source | Journal of Neurochemistry | en_US |
dc.identifier.citedreference | Alzaid A. A., Dinneen S. F., Melton L. J. 3rd, Rizza R. A. ( 1994 ) The role of growth hormone in the development of diabetic retinopathy. Diabetes Care 17, 531 – 534. | en_US |
dc.identifier.citedreference | Arner P., Sjoberg S., Gjotterberg M., Skottner A. ( 1989 ) Circulating insulin-like growth factor I in type 1 (insulin-dependent) diabetic patients with retinopathy. Diabetologia 32, 753 – 758. | en_US |
dc.identifier.citedreference | Bar R. S., Boes M., Dake B. L., Booth B. A., Henley S. A., Sandra A. ( 1988 ) Insulin, insulin-like growth factors, and vascular endothelium. Am. J. Med. 85, 59 – 70. | en_US |
dc.identifier.citedreference | Betz A. L., Bowman P. D., Goldstein G. W. ( 1983 ) Hexose transport in microvascular endothelial cells cultured from bovine retina. Exp. Eye Res. 36, 269 – 277. | en_US |
dc.identifier.citedreference | Burgos R., Mateo C., Cant N. A., Hern†ndez C., Mesa J., SimÓ R. ( 2000 ) Vitreous levels of IGF-1, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy. Diabetes Care 23, 80 – 83. | en_US |
dc.identifier.citedreference | Butler A. A., Yakar S., Gewolb I. H., Karas M., Okubo Y., LeRoith D. ( 1998 ) Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121, 19 – 26. | en_US |
dc.identifier.citedreference | Calvaruso G., Vento R., Giuliano M., Lauricella M., Gerbino E., Tesoriere G. ( 1996 ) Insulin-like growth factors in chick embryo retina during development. Regul. Pep. 61, 19 – 25. | en_US |
dc.identifier.citedreference | Cunha-Vaz J. G. ( 1976 ) The blood–retinal barriers. Doc. Ophthalmol. 41, 287 – 327. | en_US |
dc.identifier.citedreference | Dills D. G., Moss S. E., Klein R., Klein B. E. ( 1991 ) Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes. Diabetes 40, 1725 – 1730. | en_US |
dc.identifier.citedreference | Grant M., Russell B., Fitzgerald C., Merimee T. J. ( 1986 ) Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization. Diabetes 35, 416 – 420. | en_US |
dc.identifier.citedreference | Grant M., Jerdan J., Merimee T. J. ( 1987 ) Insulin-like growth factor-I modulates endothelial cell chemotaxis. J. Clin. Endo Metab 65, 370 – 371. | en_US |
dc.identifier.citedreference | Grant M. B., Mames R. N., Fitzgerald C., Ellis E. A., Aboufriekha M., Guy J. ( 1993a ) Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia 36, 282 – 291. | en_US |
dc.identifier.citedreference | Grant M. B., Mames R. N., Fitzgerald C., Ellis E. A., Caballero S., Chegini N., Guy J. ( 1993b ) Insulin-like growth factor I as an angiogenic agent. In vivo and in vitro studies. Ann. N. Y. Acad. Sci. 692, 230 – 242. | en_US |
dc.identifier.citedreference | Harik S. I., Kalaria R. N., Whitney P. M., Andersson L., Lundahl P., Ledbetter S. R., Perry G. ( 1990 ) Glucose transporters are abundant in cells with ‘occluding’ junctions at the blood–eye barriers. Proc. Natl Acad. Sci. USA 87, 4261 – 4264. | en_US |
dc.identifier.citedreference | Heasley L. E. & Johnson G. L. ( 1989 ) Regulation of protein kinase C by nerve growth factor, epidermal growth factor, and phorbol esters in PC12 pheochromocytoma cells. J. Biol. Chem 264, 8646 – 8652. | en_US |
dc.identifier.citedreference | Heilig C. W., Liu Y., England R. L., Freytag S. O., Gilbert J. D., Heilig K. O., Zhu M., Concepcion L. A., Brosius F. C. 3rd ( 1997 ) d-Glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy. Diabetes 46, 1030 – 1039. | en_US |
dc.identifier.citedreference | Hyer S. L., Sharp P. S., Brooks R. A., Burrin J. M., Kohner E. M. ( 1988 ) Serum IGF-1 concentration in diabetic retinopathy. Diabet. Med. 5, 356 – 360. | en_US |
dc.identifier.citedreference | Ishii H., Jirousek M. R., Koya D., Takagi C., Xia P., Clermont A., Bursell S. E., Kern T. S., Ballas L. M., Heath W. F., Stramm L. E., Feener E. P., King G. L. ( 1996 ) Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor [see comments]. Science 272, 728 – 731. | en_US |
dc.identifier.citedreference | Jones J. I. & Clemmons D. R. ( 1995 ) Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 3 – 34. | en_US |
dc.identifier.citedreference | Kermer P., Klocker N., Labes M., Bahr M. ( 2000 ) Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo. J. Neurosci 20, 2 – 8. | en_US |
dc.identifier.citedreference | King G. L., Buzney S. M., Kahn C. R., Hetu N., Buchwald S., Macdonald S. G., Rand L. I. ( 1983 ) Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J. Clin. Invest. 71, 974 – 979. | en_US |
dc.identifier.citedreference | King G. L., Ishii H., Koya D. ( 1997 ) Diabetic vascular dysfunctions: a model of excessive activation of protein kinase C. Kidney Int. Suppl. 60, S77 – S85. | en_US |
dc.identifier.citedreference | Knusel B., Michel P. P., Schwaber J. S., Hefti F. ( 1990 ) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10, 558 – 570. | en_US |
dc.identifier.citedreference | Kumagai A. K. ( 1999 ) Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes Metab. Rev. 15, 261 – 273. | en_US |
dc.identifier.citedreference | Kumagai A. K., Glasgow B. J., Pardridge W. M. ( 1994 ) GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Invest. Ophthalmol. Vis Sci. 35, 2887 – 2894. | en_US |
dc.identifier.citedreference | Lee H. C., Lee K. W., Chung C. H., Chung Y. S., Lee E. J., Lim S. K., Kim K. R., Huh K. B., Lee S. C., Kwon O. W. ( 1994 ) IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy. Diabetes Res. Clin. Pract. 24, 85 – 88. | en_US |
dc.identifier.citedreference | Lee W. H., Javedan S., Bondy C. A. ( 1992 ) Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development. J. Neurosci. 12, 4737 – 4744. | en_US |
dc.identifier.citedreference | LeRoith D., Werner H., Beitner-Johnson D., Roberts C. T. Jr ( 1995 ) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16, 143 – 163. | en_US |
dc.identifier.citedreference | Mantych G. J., Hageman G. S., Devaskar S. U. ( 1993 ) Characterization of glucose transporter isoforms in the adult and developing human eye. Endocrinology 133, 600 – 607. | en_US |
dc.identifier.citedreference | Merimee T. J. ( 1978 ) A follow-up study of vascular disease in growth hormone-deficient dwarfs with diabetes. N. Engl. J. Med. 298, 1217 – 1222. | en_US |
dc.identifier.citedreference | Merimee T. J., Zapf J., Froesch E. R. ( 1983 ) Insulin-like growth factors. Studies in diabetics with and without retinopathy. N. Engl. J. Med. 309, 527 – 530. | en_US |
dc.identifier.citedreference | Meyer-Schwickerath R., Pfeiffer A., Blum W. F., Freyberger H., Klein M., Losche C., Rollmann R., Schatz H. ( 1993 ) Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J. Clin. Invest. 92, 2620 – 2625. | en_US |
dc.identifier.citedreference | Mueckler M. ( 1994 ) Facilitative glucose transporters. Eur. J. Biochem. 219, 713 – 725. | en_US |
dc.identifier.citedreference | Ocrant I., Valentino K. L., King M. G., Wimpy T. H., Rosenfeld R. G., Baskin D. G. ( 1989 ) Localization and structural characterization of insulin-like growth factor receptors in mammalian retina. Endocrinology 125, 2407 – 2413. | en_US |
dc.identifier.citedreference | Pekala P., Marlow M., Heuvelman D., Connolly D. ( 1990 ) Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J. Biol. Chem 265, 18051 – 18054. | en_US |
dc.identifier.citedreference | Petley T., Graff K., Jiang W., Yang H., Florini J. ( 1999 ) Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm. Metab. Res. 31, 70 – 76. | en_US |
dc.identifier.citedreference | Poulsen J. E. ( 1953 ) Recovery from retinopathy in a case of diabetes with Simmonds' disease. Diabetes 2, 1953. | en_US |
dc.identifier.citedreference | Shiba T., Inoguchi T., Sportsman J. R., Heath W. F., Bursell S., King G. L. ( 1993 ) Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am. J. Physiol. 265, E783 – E793. | en_US |
dc.identifier.citedreference | Smith L. E., Kopchick J. J., Chen W., Knapp J., Kinose F., Daley D., Foley E., Smith R. G., Schaeffer J. M. ( 1997 ) Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276, 1706 – 1709. | en_US |
dc.identifier.citedreference | Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettigrew K. D., Sakurada O., Shinohara M. ( 1977 ) The [ 14 C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897 – 916. | en_US |
dc.identifier.citedreference | Sone H., Deo B. K., Kumagai A. K. ( 2000 ) Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest. Ophthalmol. Vis. Sci. 41, 1876 – 1884. | en_US |
dc.identifier.citedreference | Standaert M. L., Galloway L., Karnam P., Bandyopadhyay G., Moscat J., Farese R. V. ( 1997 ) Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J. Biol. Chem 272, 30075 – 30082. | en_US |
dc.identifier.citedreference | Tai P. K., Liao J. F., Chen E. H., Dietz J., Schwartz J., Carter-Su C. ( 1990 ) Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells. J. Biol. Chem. 265, 21828 – 21834. | en_US |
dc.identifier.citedreference | Takagi H., King G. L., Aiello L. P. ( 1998 ) Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes 47, 1480 – 1488. | en_US |
dc.identifier.citedreference | Takata K., Kasahara T., Kasahara M., Ezaki O., Hirano H. ( 1990 ) Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood–tissue barriers. Biochem. Biophys. Res. Commun. 173, 67 – 73. | en_US |
dc.identifier.citedreference | Tsakiridis T., McDowell H. E., Walker T., Downes C. P., Hundal H. S., Vranic M., Klip A. ( 1995 ) Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology 136, 4315 – 4322. | en_US |
dc.identifier.citedreference | Valverde A. M., Teruel T., Lorenzo M., Benito M. ( 1996 ) Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3′,5′-monophosphate. Endocrinology 137, 3832 – 3841. | en_US |
dc.identifier.citedreference | Waldbillig R. J., Fletcher R. T., Somers R. L., Chader G. J. ( 1988 ) IGF-I receptors in the bovine neural retina: structure, kinase activity and comparison with retinal insulin receptors. Exp. Eye Res. 47, 587 – 607. | en_US |
dc.identifier.citedreference | Waldbillig R. J., Pfeffer B. A., Schoen T. J., Adler A. A., Shen-Orr Z., Scavo L., LeRoith D., Chader G. J. ( 1991 ) Evidence for an insulin-like growth factor autocrine-paracrine system in the retinal photoreceptor-pigment epithelial cell complex. J. Neurochem. 57, 1522 – 1533. | en_US |
dc.identifier.citedreference | Yano H., Nakanishi S., Kimura K., Hanai N., Saitoh Y., Fukui Y., Nonomura Y., Matsuda Y. ( 1993 ) Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268, 25846 – 25856. | en_US |
dc.identifier.citedreference | Yano K., Bauchat J. R., Liimatta M. B., Clemmons D. R., Duan C. ( 1999 ) Down-regulation of protein kinase C inhibits insulin-like growth factor I-induced vascular smooth muscle cell proliferation, migration, and gene expression. Endocrinology 140, 4622 – 4632. | en_US |
dc.identifier.citedreference | Yu Y. & Sato J. D. ( 1999 ) MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J. Cell. Physiol. 178, 235 – 246. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.